{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:17:53Z","timestamp":1790075873267,"version":"4.0.1"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>Hyperphosphatemia or even serum phosphate levels within the \u201cnormal laboratory range\u201d are highly associated with increased cardiovascular disease risk and mortality in the general population and patients suffering from chronic kidney disease (CKD). As the kidney function declines, serum phosphate levels rise and subsequently induce the development of hypertension, vascular calcification, cardiac valvular calcification, atherosclerosis, left ventricular hypertrophy and myocardial fibrosis by distinct mechanisms. Therefore, phosphate is considered as a promising therapeutic target to improve the cardiovascular outcome in CKD patients. The current therapeutic strategies are based on dietary and pharmacological reduction of serum phosphate levels to prevent hyperphosphatemia in CKD patients. Large randomized clinical trials with hard endpoints are urgently needed to establish a causal relationship between phosphate excess and cardiovascular disease (CVD) and to determine if lowering serum phosphate constitutes an effective intervention for the prevention and treatment of CVD.<\/jats:p>","DOI":"10.3389\/fcell.2021.644363","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T03:32:50Z","timestamp":1614828770000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":73,"title":["Hyperphosphatemia and Cardiovascular Disease"],"prefix":"10.3389","volume":"9","author":[{"given":"Chao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongzhong","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1681\/ASN.2008040349","article-title":"Association of serum phosphate with vascular and valvular calcification in moderate CKD.","volume":"20","author":"Adeney","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa081","article-title":"Circulating uromodulin inhibits vascular calcification by interfering with pro-inflammatory cytokine signaling.","author":"Alesutan","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1042\/BST20150223","article-title":"Role of inorganic polyphosphate in mammalian cells: from signal transduction and mitochondrial metabolism to cell death.","volume":"44","author":"Angelova","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"B4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1080\/0886022X.2020.1758722","article-title":"Genome-wide identification of lncRNAs and mRNAs differentially expressed in human vascular smooth muscle cells stimulated by high phosphorus.","volume":"42","author":"Bao","year":"2020","journal-title":"Ren. Fail"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5804","DOI":"10.1073\/pnas.1800160115","article-title":"Insulin suppresses the production of fibroblast growth factor 23 (FGF23).","volume":"115","author":"B\u00e4r","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1681\/ASN.2018101016","article-title":"A pilot randomized trial of ferric citrate coordination complex for the treatment of advanced CKD.","volume":"30","author":"Block","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/ndt\/gfy318","article-title":"Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses.","volume":"34","author":"Block","year":"","journal-title":"Nephrol. Dial. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD.","volume":"23","author":"Block","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184634","article-title":"FGF23-Mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis.","volume":"20","author":"B\u00f6ckmann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1136\/heartjnl-2016-309404","article-title":"Association of inflammatory, lipid and mineral markers with cardiac calcification in older adults.","volume":"102","author":"Bortnick","year":"2016","journal-title":"Heart"},{"key":"B11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.atherosclerosis.2019.04.215","article-title":"Biomarkers of mineral metabolism and progression of aortic valve and mitral annular calcification: the multi-ethnic study of atherosclerosis.","volume":"285","author":"Bortnick","year":"2019","journal-title":"Atherosclerosis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1097\/HJH.0000000000000261","article-title":"High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin.","volume":"32","author":"Bozic","year":"2014","journal-title":"J. Hypertens."},{"key":"B13","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.kint.2019.09.034","article-title":"Magnesium prevents vascular calcification in Klotho deficiency.","volume":"97","author":"Braake","year":"2019","journal-title":"Kidney Int."},{"key":"B14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2018.02.009","article-title":"Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: the CRIC study.","volume":"271","author":"Bundy","year":"2018","journal-title":"Atherosclerosis"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12399-9","article-title":"Phosphate acts directly on the calcium-sensing receptor to stimulate parathyroid hormone secretion.","volume":"10","author":"Centeno","year":"2019","journal-title":"Nat. Commun."},{"key":"B16","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41574-018-0076-3","article-title":"Role of phosphate sensing in bone and mineral metabolism.","volume":"14","author":"Chande","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s00223-020-00696-1","article-title":"The lncRNA GAS5 inhibits the osteogenic differentiation and calcification of human vascular smooth muscle cells.","volume":"107","author":"Chang","year":"2020","journal-title":"Calcif. Tissue Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20235925","article-title":"Therapeutic effect of iron citrate in blocking calcium deposition in high pi-calcified VSMC: role of autophagy and apoptosis.","volume":"20","author":"Ciceri","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031260","article-title":"Biology of fibroblast growth factor 23: from physiology to pathology.","volume":"8","author":"Courbebaisse","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1093\/ndt\/gft203","article-title":"A comparison of calcium acetate\/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.","volume":"28","author":"Covic","year":"2013","journal-title":"Nephrol. Dial. Transplan."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11040213","article-title":"The key role of phosphate on vascular calcification.","volume":"11","author":"Cozzolino","year":"2019","journal-title":"Toxins (Basel)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1053\/j.ajkd.2015.01.009","article-title":"Serum phosphorus and progression of CKD and mortality: a meta-analysis of cohort studies.","volume":"66","author":"Da","year":"2015","journal-title":"Am. J. Kidney Di"},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1053\/j.jrn.2016.08.009","article-title":"Replacing phosphorus-containing food additives with foods without additives reduces phosphatemia in end-stage renal disease patients: a randomized clinical trial.","volume":"27","author":"de Fornasari","year":"2017","journal-title":"J. Ren. Nutr."},{"key":"B25","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/ckj\/sfz027","article-title":"Short-term effects of sevelamer-carbonate on fibroblast growth factor 23 and pulse wave velocity in patients with normophosphataemic chronic kidney disease Stage 3.","volume":"12","author":"de Krijger","year":"2019","journal-title":"Clin. Kidney J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"19502","DOI":"10.1002\/jcp.28548","article-title":"FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways.","volume":"234","author":"Dong","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3760\/cma.j.issn.0376-2491.2018.13.010","article-title":"Relationship between FGF23\/FGFR4 expression in atrial tissue and atrial fibrosis in patients with atrial fibrillation.","volume":"98","author":"Dong","year":"2018","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease.","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.atherosclerosis.2011.09.002","article-title":"Phosphate: the new cholesterol? the role of the phosphate axis in non-uremic vascular disease.","volume":"220","author":"Ellam","year":"2012","journal-title":"Atherosclerosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy.","volume":"121","author":"Faul","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.kint.2019.07.026","article-title":"Ferric citrate reduces fibroblast growth factor 23 levels and improves renal and cardiac function in a mouse model of chronic kidney disease.","volume":"96","author":"Francis","year":"2019","journal-title":"Kidney Int."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.259","article-title":"Left ventricular hypertrophy and serum phosphate in peritoneal dialysis patients.","volume":"84","author":"Gallieni","year":"2013","journal-title":"Kidney Int."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.1093\/ndt\/gfr144","article-title":"Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients.","volume":"26","author":"Gonzalez-Parra","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy.","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.atherosclerosis.2018.03.035","article-title":"Serum magnesium, phosphorus, and calcium levels and subclinical calcific aortic valve disease: a population-based study.","volume":"273","author":"Hisamatsu","year":"2018","journal-title":"Atherosclerosis"},{"key":"B36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jvs.2014.02.040","article-title":"Hyperphosphatemia induces protective autophagy in endothelial cells through the inhibition of Akt\/mTOR signaling.","volume":"62","author":"Hsu","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"B37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/nrneph.2012.92","article-title":"Klotho as a potential biomarker and therapy for acute kidney injury.","author":"Hu","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1681\/ASN.2014050465","article-title":"Klotho and phosphate are modulators of pathologic uremic cardiac remodeling.","volume":"26","author":"Hu","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.numecd.2016.11.009","article-title":"Contribution of fibroblast growth factor 23 to Framingham risk score for identifying subclinical atherosclerosis in Chinese men.","volume":"27","author":"Hu","year":"2017","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053393","article-title":"High expression of the Pi-transporter SLC20A1\/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1.","volume":"8","author":"Husseini","year":"2013","journal-title":"PLoS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.ajkd.2020.05.006","article-title":"KDOQI clinical practice guideline for nutrition in CKD: 2020 update.","volume":"76","author":"Ikizler","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"581","DOI":"10.2215\/CJN.07640711","article-title":"Acute effects of very-low-protein diet on FGF23 levels: a randomized study.","volume":"7","author":"Iorio","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD.","volume":"26","author":"Isakova","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1681\/ASN.2018101058","article-title":"Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the combine trial.","volume":"30","author":"Ix","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"B46","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.atherosclerosis.2013.09.002","article-title":"Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults.","volume":"231","author":"Jovanovich","year":"2013","journal-title":"Atherosclerosis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2215\/CJN.06080809","article-title":"Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease.","volume":"5","author":"Kalantar-Zadeh","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the multi-ethnic study of atherosclerosis.","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ. Heart Fail"},{"key":"B49","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3109\/10409237909102568","article-title":"The enzymatic replication of DNA.","volume":"7","author":"Kornberg","year":"1979","journal-title":"CRC Crit. Rev. Biochem."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00278","article-title":"Paracrine effects of FGF23 on the heart.","volume":"9","author":"Leifheit-Nestler","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/ndt\/gfv421","article-title":"Induction of cardiac FGF23\/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.","volume":"31","author":"Leifheit-Nestler","year":"2016","journal-title":"Nephrol. Dial. Transplant."},{"key":"B53","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s40265-019-01118-9","article-title":"Does the administration of sevelamer or nicotinamide modify uremic toxins or endotoxemia in chronic hemodialysis patients?","volume":"79","author":"Lenglet","year":"2019","journal-title":"Drugs"},{"key":"B54","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00109-017-1527-3","article-title":"Klotho suppresses high phosphate-induced osteogenic responses in human aortic valve interstitial cells through inhibition of Sox9.","volume":"95","author":"Li","year":"2017","journal-title":"J. Mol. Med. (Berl)"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03030317","article-title":"Randomized clinical trial of sevelamer carbonate on serum klotho and fibroblast growth factor 23 in CKD.","volume":"12","author":"Liabeuf","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1177\/2047487314536873","article-title":"Chronic kidney disease, cardiovascular disease and mortality: a prospective cohort study in a multi-ethnic Asian population.","volume":"22","author":"Lim","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jacc.2010.11.073","article-title":"Association of serum phosphate levels with aortic valve sclerosis and annular cacular health study.","volume":"58","author":"Linefsky","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000479010","article-title":"Elevated phosphate levels trigger autophagy-mediated cellular apoptosis in H9c2 cardiomyoblasts.","volume":"8","author":"Liu","year":"2017","journal-title":"Cardiorenal. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2015.02.048","article-title":"Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. sex makes a difference.","volume":"241","author":"Mart\u00edn","year":"2015","journal-title":"Atherosclerosis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.tcm.2019.07.011","article-title":"Mechanisms of mitral annular calcification.","volume":"30","author":"Massera","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"B61","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nrneph.2015.74","article-title":"Magnesium and cardiovascular complications of chronic kidney disease.","volume":"11","author":"Massy","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1042\/BCJ20190716","article-title":"All-trans retinoic acid reduces the transcriptional regulation of intestinal sodium-dependent phosphate co-transporter gene (Npt2b).","volume":"477","author":"Masuda","year":"2020","journal-title":"Biochem. J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/cvr\/cvv187","article-title":"Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.","volume":"108","author":"Mencke","year":"2015","journal-title":"Cardiovasc. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.pbj.2017.02.005","article-title":"Blood pressure and phosphate level in diabetic and non-diabetic kidney disease: results of the cross-sectional \u201cLow Clearance Consultation\u201d study.","volume":"2","author":"Mendes","year":"2017","journal-title":"Porto Biomed. J."},{"key":"B65","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.kint.2016.10.021","article-title":"Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.","volume":"91","author":"Mendoza","year":"2017","journal-title":"Kidney Int."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD.","volume":"7","author":"Mendoza","year":"2012","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1007\/s00018-018-2885-x","article-title":"Crosstalk between FGF23- and angiotensin II-mediated Ca 2+ signaling in pathological cardiac hypertrophy.","volume":"75","author":"Mhatre","year":"2018","journal-title":"Cell Mol. Life. Sci."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1152\/physrev.00022.2017","article-title":"Phosphate as a Signaling molecule and its sensing mechanism.","volume":"98","author":"Michigami","year":"2018","journal-title":"Physiol. Rev."},{"key":"B69","doi-asserted-by":"publisher","first-page":"R39","DOI":"10.1152\/ajpregu.00124.2016","article-title":"High dietary phosphate intake induces hypertension and augments exercise pressor reflex function in rats.","volume":"311","author":"Mizuno","year":"2016","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ki.2008.456","article-title":"A rat model of chronic kidney disease-mineral bone disorder.","volume":"75","author":"Moe","year":"2009","journal-title":"Kidney Int."},{"key":"B71","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease.","volume":"6","author":"Moe","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1681\/ASN.2017121254","article-title":"A controlled increase in dietary phosphate elevates bp in healthy human subjects.","volume":"29","author":"Mohammad","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1242\/jcs.204941","article-title":"Polyphosphate as a donor of high-energy phosphate for the synthesis of ADP and ATP.","volume":"130","author":"M\u00fcller","year":"2017","journal-title":"J. Cell Sci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.kint.2019.11.035","article-title":"Magnesium as a Janus-faced inhibitor of calcification.","volume":"97","author":"Nakagawa","year":"2020","journal-title":"Kidney Int."},{"key":"B75","doi-asserted-by":"publisher","first-page":"683","DOI":"10.2215\/CJN.08601209","article-title":"Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.","volume":"5","author":"Noori","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1161\/CIRCULATIONAHA.109.856070","article-title":"1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.","volume":"120","author":"Oh","year":"2009","journal-title":"Circulation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/acel.12664","article-title":"Hyperphosphatemia induces senescence in human endothelial cells by increasing endothelin-1 production.","volume":"16","author":"Olmos","year":"2017","journal-title":"Aging Cell"},{"key":"B79","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1053\/j.ajkd.2016.05.015","article-title":"Phosphate-Binding agents in adults with CKD: a network meta-analysis of randomized trials.","volume":"68","author":"Palmer","year":"2016","journal-title":"Am. J. Kidney Di"},{"key":"B80","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/ajcn\/nqaa091","article-title":"Association between serum phosphorus and subclinical coronary atherosclerosis in asymptomatic Korean individuals without kidney dysfunction.","volume":"112","author":"Park","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1097\/HJH.0000000000000659","article-title":"Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults.","volume":"33","author":"Patel","year":"2015","journal-title":"J. Hypertens."},{"key":"B82","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1161\/CIRCULATIONAHA105.541854","article-title":"Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.","volume":"112","author":"Phan","year":"2005","journal-title":"Circulation"},{"key":"B83","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/ndt\/gft310","article-title":"Aortic valve calcification in chronic kidney disease.","volume":"28","author":"Rattazzi","year":"2013","journal-title":"Nephrol. Dial. Transplan."},{"key":"B84","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2018.08.046","article-title":"CKD, arterial calcification, atherosclerosis and bone health: inter-relationships and controversies.","volume":"278","author":"Reiss","year":"2018","journal-title":"Atherosclerosis"},{"key":"B85","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1093\/jn\/nxaa148","article-title":"Supplemental nicotinamide dose-dependently regulates body phosphorus excretion via altering type II sodium-phosphate co-transporter expressions in laying hens.","volume":"150","author":"Ren","year":"2020","journal-title":"J. Nutr."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00424-016-1858-x","article-title":"Klotho modulates FGF23-mediated NO synthesis and oxidative stress in human coronary artery endothelial cells.","volume":"468","author":"Richter","year":"2016","journal-title":"Pflugers. Arch."},{"key":"B87","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ejim.2019.12.008","article-title":"Fibroblast growth factor 23 predicts carotid atherosclerosis in individuals without kidney disease. the cordioprev study.","volume":"74","author":"Rodr\u00edguez-Ortiz","year":"2020","journal-title":"Eur. J. Int. Med."},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082359","article-title":"Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update.","volume":"9","author":"Roumeliotis","year":"2020","journal-title":"J. Clin. Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/ehf2.12816","article-title":"Fibroblast growth factor 23: a biomarker of fibrosis and prognosis in heart failure with preserved ejection fraction.","volume":"7","author":"Roy","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006023.pub3","article-title":"Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).","volume":"8","author":"Ruospo","year":"2018","journal-title":"Cochrane Database. Syst. Rev."},{"key":"B91","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1681\/ASN.2009050559","article-title":"Intestinal npt2b plays a major role in phosphate absorption and homeostasis.","volume":"20","author":"Sabbagh","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116273","article-title":"Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.","volume":"9","author":"Sakaguchi","year":"2014","journal-title":"PLoS One"},{"key":"B93","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/ndt\/gfy358","article-title":"Low magnesium diet aggravates phosphate-induced kidney injury.","volume":"34","author":"Sakaguchi","year":"","journal-title":"Nephrol. Dial. Transplant."},{"key":"B94","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1681\/ASN.2018111150","article-title":"A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD.","volume":"30","author":"Sakaguchi","year":"","journal-title":"J. Am. Soc. Nephrol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/ki.2015.165","article-title":"Magnesium modifies the association between serum phosphate and the risk of progression to end-stage kidney disease in patients with non-diabetic chronic kidney disease.","volume":"88","author":"Sakaguchi","year":"2015","journal-title":"Kidney Int."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review.","volume":"74","author":"Sarnak","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1681\/ASN.2011121213","article-title":"Npt2b deletion attenuates hyperphosphatemia associated with CKD.","volume":"23","author":"Schiavi","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.jrn.2012.01.026","article-title":"Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the chronic renal insufficiency cohort study.","volume":"22","author":"Scialla","year":"2012","journal-title":"J. Ren. Nutr."},{"key":"B99","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrneph.2014.49","article-title":"Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease.","volume":"10","author":"Scialla","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/2520510","article-title":"Hyperphosphatemia and hs-CRP initiate the coronary artery calcification in peritoneal dialysis patients.","volume":"2017","author":"Shang","year":"2017","journal-title":"Biomed. Res. Int."},{"key":"B101","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1093\/eurheartj\/ehs152","article-title":"Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography.","volume":"33","author":"Shin","year":"2012","journal-title":"Eur. Heart J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","article-title":"Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?","volume":"88","author":"Shinaberger","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"B103","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3164\/jcbn.10-150","article-title":"High phosphate diet reduces atherosclerosis formation in apolipoprotein E-deficient mice.","volume":"49","author":"Shiota","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"B104","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/bcp.12117","article-title":"Phosphate: an old bone molecule but new cardiovascular risk factor.","volume":"77","author":"Shobeiri","year":"2014","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis.","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"B106","doi-asserted-by":"publisher","first-page":"H695","DOI":"10.1152\/ajpheart.00765.2018","article-title":"Hyperphosphatemia is required for initiation but not propagation of kidney failure-induced calcific aortic valve disease.","volume":"317","author":"Shuvy","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/bph.14691","article-title":"Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.","volume":"177","author":"Sikura","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1016\/j.celrep.2019.08.013","article-title":"\u03b1Klotho regulates age-associated vascular calcification and lifespan in zebrafish.","volume":"28","author":"Singh","year":"2019","journal-title":"Cell Rep."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium.","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s40265-017-0758-5","article-title":"A review of phosphate binders in chronic kidney disease: incremental progress or just higher costs?","volume":"77","author":"St. Peter","year":"2017","journal-title":"Drugs"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1093\/ndt\/gfw252","article-title":"Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway.","volume":"32","author":"Stevens","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"key":"B112","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"B113","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MNH.0000000000000618","article-title":"Fibroblast growth factor receptor as a potential candidate for phosphate sensing.","volume":"29","author":"Takashi","year":"","journal-title":"Curr. Opin. Nephrol. Hypertens"},{"key":"B114","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s40618-020-01205-9","article-title":"Phosphate-sensing and regulatory mechanism of FGF23 production.","volume":"43","author":"Takashi","year":"","journal-title":"J. Endocrinol. Invest."},{"key":"B115","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ejcn.2016.217","article-title":"Parenteral iron polymaltose changes i:c-terminal FGF23 ratios in iron deficiency, but not in dialysis patients.","volume":"71","author":"Tan","year":"2017","journal-title":"Eur. J. Clin. Nutr."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18242-9","article-title":"Formation of cell membrane component domains in artificial lipid bilayer.","volume":"7","author":"Tero","year":"2017","journal-title":"Sci. Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1681\/ASN.2018121250","article-title":"Pharmacological Npt2a inhibition causes phosphaturia and reduces plasma phosphate in mice with normal and reduced kidney function.","volume":"30","author":"Thomas","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1681\/ASN.2013121355","article-title":"Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.","volume":"26","author":"Tripepi","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.2215\/CJN.04250419","article-title":"Short-Term effects of very-low-phosphate and low-phosphate diets on fibroblast growth factor 23 in hemodialysis patients: a randomized crossover trial.","volume":"14","author":"Tsai","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B120","doi-asserted-by":"publisher","first-page":"506","DOI":"10.20945\/2359-3997000000070","article-title":"Is FGF-23 an early indicator of atherosclerosis and cardiac dysfunction in patients with gestational diabetes?","volume":"62","author":"Tuzun","year":"2018","journal-title":"Arch. Endocrinol. Metab."},{"key":"B121","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1182\/bloodadvances.2020001595","article-title":"Interplay of erythropoietin, fibroblast growth factor 23, and erythroferrone in patients with hereditary hemolytic anemia.","volume":"4","author":"van Vuren","year":"2020","journal-title":"Blood Adv."},{"key":"B122","doi-asserted-by":"publisher","first-page":"H1414","DOI":"10.1152\/ajpheart.00272.2018","article-title":"FGF23 impairs peripheral microvascular function in renal failure.","volume":"315","author":"Verkaik","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00018-019-03054-z","article-title":"Signaling pathways involved in vascular smooth muscle cell calcification during hyperphosphatemia.","volume":"76","author":"Voelkl","year":"2019","journal-title":"Cell Mol. Life. Sci."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3390\/toxins11110647","article-title":"FGF23 and phosphate-cardiovascular toxins in CKD.","volume":"11","author":"Vogt","year":"2019","journal-title":"Toxins (Basel)"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1080\/07420528.2018.1486850","article-title":"Blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients.","volume":"35","author":"Wang","year":"2018","journal-title":"Chronobiol. Int."},{"key":"B126","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41581-018-0101-8","article-title":"Evolving concepts in the pathogenesis of uraemic cardiomyopathy.","volume":"15","author":"Wang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3945\/ajcn.116.151654","article-title":"High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study.","volume":"106","author":"Yoon","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1002\/ptr.6674","article-title":"Curcumin inhibits calcification of human aortic valve interstitial cells by interfering NF-\u03baB, AKT, and ERK pathways.","volume":"34","author":"Zhou","year":"2020","journal-title":"Phytother. Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.644363\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T03:32:54Z","timestamp":1614828774000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.644363\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":127,"alternative-id":["10.3389\/fcell.2021.644363"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.644363","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"article-number":"644363"}}